Related Experiment Video
Updated: Sep 10, 2025
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Analysis of the Current Status and Characteristics of Health Economics Reporting in Clinical Practice Guidelines for
Xin Xing1,2,3,4, Guohua Zhang5, Weize Kong1,2,3
1Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, P. R. China.
Objective:
While prior investigations into the reporting of health economics (HE) have predominantly focused on guideline analyses at singular institutional or national levels, this study extends its scope to encompass diverse guidance documents issued transnationally across multiple institutions. Specifically, we evaluated the reporting of HE evidence in international clinical practice guidelines (CPGs) and expert consensus statements published between 2021 and 2023. The findings aim to inform the future revisions and development of such documents.
Methods:
A systematic PubMed search identified relevant CPGs and expert consensus statements within a specified period. Two independent researchers screened the literature, extracted economic evidence integrated into these documents, and employed descriptive analysis to summarize the reporting characteristics.
Results:
Of the 8931 screened publications, 3119 (34.9%) reported HE evidence. Among these 3119 publications, 237 (7.6%) incorporated HE evidence in formulating recommendations, 220 (7.1%) utilized HE evidence for evidence grading, and 2581 (82.8%) referenced HE evidence in explanatory notes accompanying the recommendations.
Conclusions:
Current CPGs and expert consensus statements exhibit low rates of HE evidence reporting, indicating that most international guideline developers have overlooked their applications. HE evidence-through cost-effectiveness and cost-utility analyses-can optimize medical resource allocation, support clinicians in patient-centered economic decision-making, and enhance health outcomes. Future guideline development should prioritize HE evidence integration to advance the scientific rigor and clinical applicability of the recommendations.
Related Concept Videos
01:29Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:26Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
01:16Clinical Trials
There are four phases in a clinical trial. A phase one...
01:30Health Information Technology and Healthcare Information System
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
01:19Standards of Care II